Marsha Fanucci - Net Worth and Insider Trading

Marsha Fanucci Net Worth

The estimated net worth of Marsha Fanucci is at least $669,493 dollars as of 2024-11-13. Marsha Fanucci is the Director of Momenta Pharmaceuticals Inc and owns about 9,000 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $472,320. Marsha Fanucci is the Director of Ironwood Pharmaceuticals Inc and owns about 44,863 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $197,173. Marsha Fanucci is also the Director of Alnylam Pharmaceuticals Inc and owns about 0 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $0. Details can be seen in Marsha Fanucci's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marsha Fanucci has not made any transactions after 2019-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Marsha Fanucci

To

Marsha Fanucci Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marsha Fanucci owns 6 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Forma Therapeutics Holdings Inc (FMTX) , and Cyclerion Therapeutics Inc (CYCN) among others .

Click here to see the complete history of Marsha Fanucci’s form 4 insider trades.

Insider Ownership Summary of Marsha Fanucci

Ticker Comapny Transaction Date Type of Owner
ALNY Alnylam Pharmaceuticals Inc 2019-11-20 director
FMTX Forma Therapeutics Holdings Inc 2020-06-18 director
CYCN Cyclerion Therapeutics Inc 2019-03-14 director
LIMIT LIMIT 2016-06-29 director
LIMIT LIMIT 2015-03-18 director
LIMIT LIMIT 2016-06-23 director

Marsha Fanucci Latest Holdings Summary

Marsha Fanucci currently owns a total of 3 stocks. Among these stocks, Marsha Fanucci owns 9,000 shares of Momenta Pharmaceuticals Inc (MNTA) as of March 15, 2013, with a value of $472,320 and a weighting of 70.55%. Marsha Fanucci owns 44,863 shares of Ironwood Pharmaceuticals Inc (IRWD) as of March 18, 2015, with a value of $197,173 and a weighting of 29.45%. Marsha Fanucci also owns 0 shares of Alnylam Pharmaceuticals Inc (ALNY) as of November 20, 2019, with a value of $0 and a weighting of 0%.

Latest Holdings of Marsha Fanucci

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MNTA Momenta Pharmaceuticals Inc 2013-03-15 9,000 52.48 472,320
IRWD Ironwood Pharmaceuticals Inc 2015-03-18 44,863 4.40 197,173
ALNY Alnylam Pharmaceuticals Inc 2019-11-20 0 268.95 0

Holding Weightings of Marsha Fanucci


Marsha Fanucci Form 4 Trading Tracker

According to the SEC Form 4 filings, Marsha Fanucci has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 29,400 shares on March 15, 2013, which brought Marsha Fanucci around $416,010.

According to the SEC Form 4 filings, Marsha Fanucci has made a total of 0 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years. The most-recent trade in Ironwood Pharmaceuticals Inc is the sale of 31,339 shares on March 18, 2015, which brought Marsha Fanucci around $491,396.

According to the SEC Form 4 filings, Marsha Fanucci has made a total of 1 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 75,000 shares on November 20, 2019, which brought Marsha Fanucci around $8 Million.

Insider Trading History of Marsha Fanucci

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marsha Fanucci Trading Performance

GuruFocus tracks the stock performance after each of Marsha Fanucci's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marsha Fanucci is -15.94%. GuruFocus also compares Marsha Fanucci's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marsha Fanucci within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Marsha Fanucci's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Marsha Fanucci

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.42 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Marsha Fanucci Ownership Network

Ownership Network List of Marsha Fanucci

No Data

Ownership Network Relation of Marsha Fanucci

Insider Network Chart

Marsha Fanucci Owned Company Details

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

Marsha Fanucci is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, Marsha Fanucci made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 52,531 shares made by Yvonne Greenstreet , a net sale of 10,304 shares made by Pushkal Garg , and a net sale of 5,639 shares made by Jeffrey V. Poulton .

In summary, during the past 3 months, insiders sold 15,000 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 249,128 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 249,128 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

Marsha Fanucci Mailing Address

Above is the net worth, insider trading, and ownership report for Marsha Fanucci. You might contact Marsha Fanucci via mailing address: Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge Ma 02139.